Evidence map›Paper›PMID 25491204›Full record

ArticleBMC medical genetics2014

Identification of novel PKD1 and PKD2 mutations in Korean patients with autosomal dominant polycystic kidney disease.

Rihwa Choi, Hayne Cho Park, Kyunghoon Lee, Myoung-Gun Lee, Jong-Won Kim, Chang-Seok Ki, Young-Hwan Hwang, Curie Ahn

Open access · goldAbstract read
In one paragraph

Article in BMC medical genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Molecular genetic analysis of polycystic kidney disease 1 and polycystic kidney disease 2 mutations in pedigrees with autosomal dominant polycystic kidney disease.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2019
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Rihwa ChoiDepartment of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, (135-710) 81 Irwon-Ro Gangnam-gu, Seoul, South Korea. rihwa.choi@samsung.com.
Hayne Cho ParkDepartment of Internal Medicine, Seoul National University College of Medicine, (110-744) 28 Yeongeon-dong, Jongno-gu, Seoul, South Korea. haynepark798@gmail.com.
Kyunghoon LeeDepartment of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, (135-710) 81 Irwon-Ro Gangnam-gu, Seoul, South Korea. kama.kyunghoon@gmail.com.
Myoung-Gun LeeDepartment of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, (135-710) 81 Irwon-Ro Gangnam-gu, Seoul, South Korea. mk01.lee@samsung.com.
Jong-Won KimDepartment of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, (135-710) 81 Irwon-Ro Gangnam-gu, Seoul, South Korea. kimjw@skku.edu.
Chang-Seok KiDepartment of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, (135-710) 81 Irwon-Ro Gangnam-gu, Seoul, South Korea. changski@skku.edu.
Young-Hwan HwangDepartment of Internal Medicine, Eulji General Hospital, (139-872), 1306 Dunsan 2(i)-dong, Seo-gu, Daejeon, Seoul, South Korea. ondahl@eulji.ac.kr.
Curie AhnDepartment of Internal Medicine, Seoul National University College of Medicine, (110-744) 28 Yeongeon-dong, Jongno-gu, Seoul, South Korea. curie@snu.ac.kr.
Samsung Medical Center · KRSeoul National University · KRSungkyunkwan University · KREulji General Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAutosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disorder. It is caused by mutations in the PKD1 and PKD2 genes, and manifests as progressive cyst growth and renal enlargement, resulting in renal failure. Although there have been a few studies on the frequency and spectrum of mutations in PKD1 and PKD2 in Korean patients with ADPKD, only exons 36-46, excluding the duplicated region, were analyzed, which makes it difficult to determine accurate mutation frequencies and mutation spectra.

methodsWe performed sequence analysis of 20 consecutive unrelated ADPKD patients using long-range polymerase chain reaction (PCR) to avoid pseudogene amplification, followed by exon-specific PCR and sequencing of the all exons of these two genes. Multiplex ligation-dependent probe amplification was performed in patients in whom pathogenic mutations in PKD1 or PKD2 were not identified by LR-PCR and direct sequencing to detect large genomic rearrangements.

resultsAll patients met the diagnostic criteria of ADPKD, and pathogenic mutations were found in 18 patients (90.0%), comprising 15 mutations in PKD1 and three in PKD2. Among 10 novel mutations, eight mutations were found in the PKD1 gene while two mutations were found in the PKD2 gene. Eight of 14 PKD1 mutations (57.1%) were located in the duplicated region.

conclusionsThis study expands the spectra of mutations in the PKD1 and PKD2 genes and shows that the mutation frequencies of these genes in Korean ADPKD patients are similar to those reported in other ethnicities. Sequence analysis, including analysis of the duplicated region, is essential for molecular diagnosis of ADPKD.

Indexed as

AdultAsian PeopleDNA Mutational AnalysisFemaleGene DuplicationHumansMaleMiddle AgedMutationPolycystic Kidney, Autosomal DominantRepublic of KoreaTRPP Cation ChannelsTRPP Cation Channels

Identifiers

PMID25491204
PMCPMC4411869
OpenAlexW2095026351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.